SZSE:002773 (China)
Â
Class A
Â¥
27.16
+2.21 (+8.86%)
Apr 1
What is a stock summary page? Click here for an overview.
Business Description
Chengdu Kanghong Pharmaceutical Group Co Ltd
ISIN : CNE1000020C4
Share Class Description:
SZSE:002773: Class ACompare
Compare
Traded in other countries / regions
002773.China Index Membership
SZSE Component IndexCSI 300 IndexSZSE SME Price Index IPO Date
2015-06-26Description
Chengdu Kanghong Pharmaceutical Group Co Ltd is a pharmaceutical company. The company is engaged in the research and development, production, and sales of medicine, chemical medicine, and biological products.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 882.55 | |||||
| Equity-to-Asset | 0.92 | |||||
| Debt-to-EBITDA | 0.01 | |||||
| Interest Coverage | 872.11 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 20.14 | |||||
| Beneish M-Score | -2.69 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.5 | |||||
| 3-Year Book Growth Rate | 10.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 14.71 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 11.54 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 74.45 | |||||
| 9-Day RSI | 74.44 | |||||
| 14-Day RSI | 73.64 | |||||
| 3-1 Month Momentum % | -1.68 | |||||
| 6-1 Month Momentum % | -10.12 | |||||
| 12-1 Month Momentum % | 9.18 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 8.43 | |||||
| Quick Ratio | 7.88 | |||||
| Cash Ratio | 7.54 | |||||
| Days Inventory | 319.91 | |||||
| Days Sales Outstanding | 15.13 | |||||
| Days Payable | 225.36 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 1.52 | |||||
| Dividend Payout Ratio | 0.29 | |||||
| 3-Year Dividend Growth Rate | -18.8 | |||||
| Forward Dividend Yield % | 1.52 | |||||
| 5-Year Yield-on-Cost % | 0.67 | |||||
| 3-Year Average Share Buyback Ratio | 0.1 | |||||
| Shareholder Yield % | 1.52 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 89.54 | |||||
| Operating Margin % | 30.14 | |||||
| Net Margin % | 27.3 | |||||
| FCF Margin % | 30.07 | |||||
| ROE % | 14.86 | |||||
| ROA % | 13.61 | |||||
| ROIC % | 34.66 | |||||
| 3-Year ROIIC % | 884.8 | |||||
| ROC (Joel Greenblatt) % | 55.3 | |||||
| ROCE % | 16.27 | |||||
| Years of Profitability over Past 10-Year | 9 |
GF Value Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 20.89 | |||||
| Forward PE Ratio | 17.53 | |||||
| PE Ratio without NRI | 20.81 | |||||
| Shiller PE Ratio | 37.72 | |||||
| Price-to-Owner-Earnings | 29.88 | |||||
| PS Ratio | 5.69 | |||||
| PB Ratio | 2.96 | |||||
| Price-to-Tangible-Book | 3.11 | |||||
| Price-to-Free-Cash-Flow | 18.96 | |||||
| Price-to-Operating-Cash-Flow | 16.99 | |||||
| EV-to-EBIT | 13.22 | |||||
| EV-to-EBITDA | 13.22 | |||||
| EV-to-Revenue | 3.98 | |||||
| EV-to-FCF | 13.67 | |||||
| Price-to-GF-Value | 1.19 | |||||
| Price-to-Projected-FCF | 2.47 | |||||
| Price-to-Graham-Number | 1.7 | |||||
| Price-to-Net-Current-Asset-Value | 4.6 | |||||
| Price-to-Net-Cash | 5.24 | |||||
| Earnings Yield (Greenblatt) % | 7.56 | |||||
| FCF Yield % | 5.26 | |||||
| Forward Rate of Return (Yacktman) % | 12.37 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Chengdu Kanghong Pharmaceutical Group Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 4,369.941 | ||
| EPS (TTM) (Â¥) | 1.3 | ||
| Beta | 0.79 | ||
| 3-Year Sharpe Ratio | 0.17 | ||
| 3-Year Sortino Ratio | 0.26 | ||
| Volatility % | 45.54 | ||
| 14-Day RSI | 73.64 | ||
| 14-Day ATR (Â¥) | 0.880292 | ||
| 20-Day SMA (Â¥) | 22.1215 | ||
| 12-1 Month Momentum % | 9.18 | ||
| 52-Week Range (Â¥) | 16.62 - 27.45 | ||
| Shares Outstanding (Mil) | 919.78 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Chengdu Kanghong Pharmaceutical Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Chengdu Kanghong Pharmaceutical Group Co Ltd Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Chengdu Kanghong Pharmaceutical Group Co Ltd Frequently Asked Questions
What is Chengdu Kanghong Pharmaceutical Group Co Ltd(SZSE:002773)'s stock price today?
The current price of SZSE:002773 is ¥27.16. The 52 week high of SZSE:002773 is ¥27.45 and 52 week low is ¥16.62.
When is next earnings date of Chengdu Kanghong Pharmaceutical Group Co Ltd(SZSE:002773)?
The next earnings date of Chengdu Kanghong Pharmaceutical Group Co Ltd(SZSE:002773) is .
Does Chengdu Kanghong Pharmaceutical Group Co Ltd(SZSE:002773) pay dividends? If so, how much?
The Dividend Yield %  of Chengdu Kanghong Pharmaceutical Group Co Ltd(SZSE:002773) is 1.52% (As of Today), Highest Dividend Payout Ratio of Chengdu Kanghong Pharmaceutical Group Co Ltd(SZSE:002773) was 0.3. The lowest was 0.11. And the median was 0.19. The  Forward Dividend Yield % of Chengdu Kanghong Pharmaceutical Group Co Ltd(SZSE:002773) is 1.52%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers